STEC

PATEO, a Leading Enterprise in Automotive Intelligence Industry, Secures Another Equity Financing of Approximately 1.5 Billion Yuan

Retrieved on: 
Tuesday, March 26, 2024
STEC, Dongfeng Motor Corporation, Attention, China Construction Bank, ICBC, Intelligence, Xiaomi, CCP, Capital, YRD, CCB, DFM, Trust, FAW Group, Industrial, FAW, Intellectual property, Yangtze Delta, Automotive industry, Multimedia, Commercial bank, Renewable energy

According to relevant resources, PATEO has recently obtained another financing of 1.5 billion yuan.

Key Points: 
  • According to relevant resources, PATEO has recently obtained another financing of 1.5 billion yuan.
  • While completing this equity financing, PATEO also signed a 19 billion yuan credit agreement with seven top state-owned banks, including Industrial and Commercial Bank of China (ICBC) and China Construction Bank (CCB).
  • In the second half of electric vehicle race, intelligence is the core for automakers to create product differentiation, hence the accelerated iteration of automotive product architecture and form.
  • As an intelligence supplier with self-owned core technologies, PATEO has entered a period of leapfrog growth from 1 to 10 with the development of the industry.

Arizona Approves SaniDate® 12.0 for Human Health Pathogen Control in Agricultural Irrigation Waters!

Retrieved on: 
Thursday, November 30, 2023
FSMA, STEC, O157, H7, Multimedia, SLN, Suleman Adamu Sanid, Salmonella enterica, University, Food safety, Salmonella, Agriculture

EAST HARTFORD, Conn., Nov. 30, 2023 /PRNewswire/ -- Just in time for fall/winter vegetable season, BioSafe Systems' product SaniDate® 12.0 received a FIFRA 24(c) Special Local Need (SLN) label in Arizona to control foodborne human health pathogens in agricultural irrigation water.

Key Points: 
  • EAST HARTFORD, Conn., Nov. 30, 2023 /PRNewswire/ -- Just in time for fall/winter vegetable season, BioSafe Systems' product SaniDate® 12.0 received a FIFRA 24(c) Special Local Need (SLN) label in Arizona to control foodborne human health pathogens in agricultural irrigation water.
  • Specifically, SaniDate 12.0 is the only labeled product that can be used for the reduction and control of Shiga Toxin-producing Escherichia coli (STEC), including O157:H7 and Salmonella enterica in preharvest agriculture water.
  • SaniDate 12.0 is one of the first products to receive this 24(c) SLN, reinforcing BioSafe Systems' dedication to strengthening food safety not only in the state of Arizona but throughout the country.
  • A special local need label may also be produced if the product is more effective or less harmful than the one currently in use.

Case Series of Three Critically Ill Children with Acute Kidney Injury Safely Treated with SeaStar Medical’s Selective Cytopheretic Device Published in the Journal Blood Purification

Retrieved on: 
Tuesday, August 29, 2023
STEC, Neutrophil, Multiple organ dysfunction syndrome, SCD, Systemic, AKI, STEC-HUS, Acute kidney injury, CKRT, Hospital, MD, Immunomodulation, Observation, Paper, SeaStar, ICU, Cincinnati, Karger Publishers, Pharmaceutical industry

All three children were in the ICU at two different hospitals and treated with continuous kidney replacement therapy (CKRT).

Key Points: 
  • All three children were in the ICU at two different hospitals and treated with continuous kidney replacement therapy (CKRT).
  • Each show gradual improvement following treatment with the SCD-PED and normalization or near normalization of kidney function at 60-day follow up.
  • The article, “Hemolytic Uremic Syndrome-Induced Acute Kidney Injury Treated via Immunomodulation with the Selective Cytopheretic Device: Cases of STEC-HUS Treated with Immunomodulation via SCD CRRT Filter,” (H. Rhodes Hambrick, et al.)
  • was published in the peer-reviewed journal Blood Purification.

Meridian Bioscience Announces FDA Clearance for Innovative Curian® Shiga Toxin Assay

Retrieved on: 
Wednesday, April 19, 2023
HUS, STEC, Human, Subjectivity, Workflow, Syndrome, Infection, Campylobacter, Shiga toxin, STX1A, Patient, LIS, FDA, GI, Pharmaceutical industry, Meridian

CINCINNATI, April 19, 2023 /PRNewswire/ -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today that the United States Food and Drug Administration (FDA) had granted clearance for the company's new Curian® Shiga Toxin assay.

Key Points: 
  • CINCINNATI, April 19, 2023 /PRNewswire/ -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today that the United States Food and Drug Administration (FDA) had granted clearance for the company's new Curian® Shiga Toxin assay.
  • This assay joins Curian HpSA® and Curian Campy as Meridian expands its Curian diagnostic platform to maintain leadership in the gastrointestinal disease testing market.
  • The Curian Shiga Toxin assay is designed for use with the Curian analyzer.
  • The new assay is a rapid, qualitative, fluorescent immunoassay for the simultaneous detection and differentiation of Shiga toxin 1 (Stx1) and Shiga toxin 2 (Stx2) in a single test device.

Molecular Designs releases their new Simplicity™ Gastrointestinal Pathogen Panel

Retrieved on: 
Tuesday, April 11, 2023
GMP, STEC, Yersinia enterocolitica, Clostridioides difficile, ISO, Molecular design software, ETEC, Research, Escherichia coli, Entamoeba histolytica, Rotavirus, Giardia duodenalis, Dicarboxylic acid, EIEC, Polymerase chain reaction, Laboratory, Adenoviridae, GI, PCR, Pharmaceutical industry, Campylobacter

BIRMINGHAM, Ala., April 11, 2023 /PRNewswire/ -- Molecular Designs, a developer and manufacturer of molecular infectious disease assays , announces the release of its new Simplicity™ Gastrointestinal Pathogen Panel for the detection of causative agents of gastrointestinal (GI) tract infections.

Key Points: 
  • BIRMINGHAM, Ala., April 11, 2023 /PRNewswire/ -- Molecular Designs, a developer and manufacturer of molecular infectious disease assays , announces the release of its new Simplicity™ Gastrointestinal Pathogen Panel for the detection of causative agents of gastrointestinal (GI) tract infections.
  • The GI panel is a multiplex PCR assay that identifies nucleic acids from 16 different organisms, from a single sample.
  • Molecular Designs assays are manufactured to GMP and ISO 13485:2016 standards and are compatible with most PCR platforms.
  • "Our Simplicity Gastrointestinal Pathogen Panel is available to reference and hospital laboratories," said Robert Crisp , Ph.D., Vice President of Research & Development at Molecular Designs.

Energis Launches Revolutionary Solution to Eliminate Food-Borne Pathogens in Meat

Retrieved on: 
Thursday, February 9, 2023
Campylobacter, FDA, Organic, Meat, Lactic acid, Food safety, Environment, Water, STEC, Poultry, EPA, Salmonella, Quality, Poultry farming, Vaccine, Listeria, Electrophorus voltai

DENVER, Feb. 9, 2023 /PRNewswire/ -- Energis Solutions™ announces the third-party validation and submittal to the FDA for approval of the Voltai™ technology for the meat protein industry. The solution is produced via an on-demand, onsite machine that can easily be adapted into most any existing manufacturing process. Voltai™ significantly reduces eminent food-borne pathogens that continue to challenge the meat industry. Darin Jensen, Vice President of Food Safety, Quality & Regulatory with Energis was excited about bringing the Voltai technology solution to the beef and poultry industry.

Key Points: 
  • The solution is produced via an on-demand, onsite machine that can easily be adapted into most any existing manufacturing process.
  • Voltai™ significantly reduces eminent food-borne pathogens that continue to challenge the meat industry.
  • Darin Jensen, Vice President of Food Safety, Quality & Regulatory with Energis was excited about bringing the Voltai technology solution to the beef and poultry industry.
  • The Voltai solution targets STEC, Salmonella, Campylobacter and Listeria amongst other pesty pathogens.

Guardian™ Technology by Energis Achieves Pathogen Reduction Milestone in Wheat Temper

Retrieved on: 
Tuesday, January 10, 2023
STEC, Partnership, Salmonella, Treatment, Corrosion, Flour, Food preservation, Energis

DENVER, Jan. 10, 2023 /PRNewswire/ -- Energis Solutions™ has released results from a recent validated study confirming its pathogen reduction technology, Guardian™, which is highly effective in reducing common pathogens found in the wheat tempering process. The study shows Guardian™ performs at a 225% higher kill rate than acid based(1) solutions without leaving chemical residuals or altering the functionality of wheat and flour.

Key Points: 
  • Validated 3rd party study confirms an average 5.40 log reduction of pathogens in wheat temper with the Guardian™ System.
  • DENVER, Jan. 10, 2023 /PRNewswire/ -- Energis Solutions™ has released results from a recent validated study confirming its pathogen reduction technology, Guardian™, which is highly effective in reducing common pathogens found in the wheat tempering process.
  • As part of the study, Hard Red Winter wheat was inoculated with E. faecium (salmonella) and e-coli (STEC) and then treated using Energis Solutions™, Guardian™, Treatment technology.
  • Results showed an average 5.40 log reduction of e-coli and an average 3.93 log reduction of salmonella when analyzed against the non-treated control samples.

Eligo Bioscience Receives FDA Orphan Drug Designation (ODD) and Rare Pediatric Disease (RPD) Designation for EB003 for the Prevention of Hemolytic Uremic Syndrome with First-in-class CRISPR-based medicine

Retrieved on: 
Tuesday, October 11, 2022
RPD, Shiga toxin, Disease, Technology, IND, Royal commission, Escherichia coli, Genetically modified bacteria, World Economic Forum, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Patient, Synthetic biology, Gene editing, DNA repair, Genetic engineering, Rockefeller University, Platelet, ODD, Acute kidney injury, Dysentery, Food, Anemia, GlaxoSmithKline, Khosla Ventures, Microdeletion syndrome, MIT, STEC, CRISPR, PRV, Bacteria, BLA, DNA, HUS, Death, FDA, Gene, Solution, European Commission, Biologics license application, Pharmaceutical industry, Vaccine, Antibiotics, Shiga Prefecture

Children under 5 years of age are particularly sensitive to the expression of Shiga toxins from E. coli (STEC) bacteria after their ingestion from contaminated foods.

Key Points: 
  • Children under 5 years of age are particularly sensitive to the expression of Shiga toxins from E. coli (STEC) bacteria after their ingestion from contaminated foods.
  • EB003 is IND-enabled with a robust manufacturing process at the 100L-scale, full preclinical package and a clear regulatory path-to-clinic.
  • The FDA grants Orphan Drug Designation to a drug or biologic intended to treat a rare disease or condition, which generally includes a disease or condition that affects fewer than 200,000 individuals in the U.S.
  • The FDA grants Rare Pediatric Disease designation for serious and life-threatening diseases primarily affecting individuals ages 18 or younger and fewer than 200,000 individuals in the United States.

Number of Victims in the Wendy's E. Coli Outbreak Grows to 97 in 6 States: Ron Simon & Associates Files First Michigan Lawsuit and Anticipates New Cases Will be Identified Over the Labor day Weekend

Retrieved on: 
Friday, September 2, 2022
Escherichia coli, Wendy's, Office of Inspector General, U.S. Department of Health and Human Services, Public health, Legislation, STEC, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, NBC, H7, Food Safety and Inspection Service, Feces, HUS, Food, Dysentery, CNN, Multimedia, Double, Abdominal pain, U.S. Department of Agriculture Cotton Annex, FOX, Center, Television, FDA, Centers for Disease Control and Prevention timeline, Dave, Microdeletion syndrome, Food safety, ABC, Poisoning, Bacteria, CDC, Lettuce, Nausea, CBS, Poultry

These numbers are expected to increase significantly over the next few weeks.

Key Points: 
  • These numbers are expected to increase significantly over the next few weeks.
  • E. coli is a bacteria that is usually transmitted through human feces, and early indications point to Romaine lettuce on Wendy's sandwiches.
  • Over the last 20 years, Ron Simon and his colleagues have prosecuted thousands of food poisoning cases for victims across the United States.
  • He regularly publishes articles about food safety and litigation at www.foodpoisoningnews.com which are read by viewers in over 180 countries.

QIAGEN Expands Syndromic Testing Portfolio with the Launch of Higher-Capacity QIAstat-Dx Rise and Enhanced Panels

Retrieved on: 
Monday, May 16, 2022
Security, Data Management, Technology, Pharmaceutical, General Health, Infectious Diseases, Hospitals, Genetics, Clinical Trials, Biotechnology, Science, Software, Networks, Internet, Research, Health, Senior, QIAGEN, Risk, DNA, Blood, QGEN, U.S. Securities and Exchange Commission, Urinary tract infection, Bacteria, Solution, Knowledge, HUS, Molecular diagnostics, Research, Life, RNA, Budget, STEC, Automation, Protein, SEC, Hemolytic–uremic syndrome, Growth, Laboratory, NYSE, Chlamydia pneumoniae, Vaccine, Academy, Insight, Pharma

The launch of QIAstat-Dx Rise comes after the award of European CE-marking that significantly expands QIAGENs offering in syndromic testing, which is becoming an increasingly important tool in laboratories settings to test simultaneously for multiple pathogens from one sample.

Key Points: 
  • The launch of QIAstat-Dx Rise comes after the award of European CE-marking that significantly expands QIAGENs offering in syndromic testing, which is becoming an increasingly important tool in laboratories settings to test simultaneously for multiple pathogens from one sample.
  • The launch of QIAstat-Dx Rise syndromic testing platform provides automated, comprehensive pathogen testing for higher-demand medical institutions, said Jean-Pascal Viola, Senior Vice President, Head of the Molecular Diagnostics Business Area at QIAGEN.
  • QIAstat-Dx Rise and its test cartridges are a closed system for hands-off sample preparation and processing.
  • Building on the existing QIAstat-Dx Analyzer with up to four analytical modules, QIAstat-Dx Rise is a flexible new option for increased testing capacity.